Title
Author
DOI
Article Type
Special Issue
Volume
Issue
1Department of Biomedical Technologies, School of Dental Medicine, University of Siena, 53100 Siena, Italy
2Unit of Oral and Maxillofacial Surgery, Ca’Foncello Hospital, 31100 Treviso, Italy
*Corresponding Author(s):matteo.val@outlook.it (Matteo Val)
| History | Submitted: 17 July 2024 | Accepted: 12 October 2024 | Published: 12 March 2025 |
| Copyright: | ©2025 The Author(s). Published by MRE Press. |

Background: Calcium pyrophosphate dihydrate deposition disease (CPPD) is a metabolic disease resulting in acute arthritis. CPPD often affects joints containing fibrocartilage. The purpose of this review is to examine the clinical presentations, prevalence, and treatment modalities associated with CPPD when it affects the temporomandibular joint (TMJ). Methods: A search, following PRISMA guideline, was conducted in various electronic databases (PubMed, Scopus, Web of Science) to find relevant studies about CPPD in the temporomandibular joint. The search spanned from 01 January 1980, to 31 January 2024. A case report was also presented. Results: A systematic review of literature identified 64 papers, reaching a total of 74 cases of CPPD of the temporomandibular joint TMJ. CPPD is a condition that typically affects middle-aged or older patients, with an average age of around 60 at the time of diagnosis. Females are affected more frequently than males. Most cases involve unilateral TMJ involvement, and common symptoms include pain, reduced mouth opening, and swelling. Different papers also describe severe stages of the invasion of muscles, parotid gland, and even brain structure. Surgery has the preferred treatment option for most Authors and is mandatory for late-stage lesions. The recurrence rate is extremely low. Conclusions: CPPD is an uncommon, locally invasive, and typically benign condition that rarely affects the TMJ. Distinguishing CPDD in the TMJ from other neoplasms poses diagnostic challenges. A definitive diagnosis necessitates histological examination and quantitative microanalysis. In our patient, successful excision of CPDD in the TMJ was achieved using an external approach. The PROSPERO Registration: PROSPERO number is CRD42024558402.
Cite this article
Matteo Val, Mirko Ragazzo, Anna Colonna, Marco Ferrari, Edoardo Ferrari Cagidiaco, Daniele Manfredini, Luca Guarda Nardini. Pseudogout of the temporomandibular joint: a case report with systematic literature review. Journal of Oral & Facial Pain and Headache. 2025; 39(1): 49-69. doi: 10.22514/jofph.2025.004
Calcium pyrophosphate dihydrate deposition disease (CPPD) is a metabolic disorder that causes non-infectious inflammation in joints and can lead to calcification either within or around the joint [1]. In 1962, Kohn et al. [2] were the first to document the presence of CPPD crystals in the synovial fluid of the knee in patients with “chondrocalcinosis”, characterized by cartilage calcifications on standard radiographs [3] along with acute symptoms associated with gout. Chondrocalcinosis is commonly used as a marker for the presence of CPPD in population-based studies, and its occurrence is closely linked to aging. Radiological evidence of chondrocalcinosis is observed in 6% to 15% of patients above the age of 60. This prevalence increases to 30% to 40% in patients aged over 80 years [1]. Despite the knowledge on the disease, many instances are probably not being diagnosed correctly [4].
Furthermore, Willekens et al. [5] pointed out that individuals with peripheral calcific disease are more likely to have involvement of the temporomandibular joint (TMJ) than previously believed.
The involvement of the TMJ by CPPD exhibits signs and symptoms that closely resemble various other temporomandibular joint disorders. Consequently, inexperienced professionals may attempt multiple management approaches, often resulting in a delayed or missed diagnosis [6, 7], which is a common occurrence in this type of pathology [8, 9, 10, 11]. Therefore, accurate classification of the patient using evidence-based methods is imperative [12, 13, 14].
Information on CPPD is currently limited. The prevalence of this condition remains unknown, and milder forms may be underdiagnosed. Additionally, effective treatment for CPPD affecting the temporomandibular joints has yet to be established, unlike for other joint involvements.
Based on this premise, it seems interesting to get deeper into the description of pseudogout of the TMJ. In this manuscript, we report a clinical case of large TMJ pseudogout as well as a systematic review of the existing literature, with the aim to share information about the prevalence, management and follow-up of patients with CPPD.
An 87-year-old Caucasian female was referred to the Unit of Oral and Maxillofacial Surgery in September 2022 for the evaluation of a firm swelling located over her left TMJ. The patient had been experiencing chronic left TMJ pain for over 2 years. Despite seeking medical advice from multiple healthcare providers during this period, she did not receive a definitive diagnosis. Her dentist tried different medical treatment, including anti-inflammatory (ibuprofen) associated with amoxicillin + clavulanic acid 875 + 125 mg (1 pill every 8 hours for 7 days), without success. Then a second dentist produced an oral device trying to reduce overload and the swelling to the TMJ, but there were no improvements. Her past medical history includes diabetes, hypercholesterolemia and hypoacusia. She was receiving treatment that included aspirin, insulin, metformin, gliclazide and statins. The patient denied any history of trauma or infection to the jaw area.
Upon examination, a localized swelling was identified in the left pre-auricular region, measuring approximately 30 mm. The area exhibited tenderness upon palpation and showed a firm, bony texture. The patient complained of mouth limitation and lateral deviation of the mandible when mouth opening. No other symptoms were reported by the patient.
A computerized tomography (CT) was performed due to the suspect of a neoformation of the left TMJ. From the radiological examination was highlighted a massive radiopaque lesion (major diameter 39 mm) was shown that embroidered the head of the left condyle, which appeared degenerated as the glenoid fossa, with some minor defects also evident in the roof of the fossa (Fig. 1). Based on the patient’s primary clinical characteristics and radiological findings, the differential diagnosis included tumor or tumor-like conditions, such as pigmented villonodular synovitis (PVNS), synovial chondromatosis, and the potential for malignant chondrosarcoma of the right temporomandibular joint (TMJ). The patient underwent surgical removal of the mass under general anaesthesia through a preauricular approach followed by tissue dissection. During the procedure, the mass was found to be an encapsulated soft tissue mass originating and surrounding from the circumference of the articular disk (Fig. 2). Once the capsule was cute a nodular, friable, gritty granulomatous tissue emerged. It was excised in two separate portions. Arthroplasty was performed using a burr to re-establish the correct shape of the mandibular condyle. The incision is subsequently closed using layered sutures. Upon microscopic examination, it was observed that there were nodules of birefringent crystalline material and calcifications present, which were associated with reactive chondroblasts and histiocytes. The integrity of the crystals during processing indicated the presence of calcium pyrophosphate crystal deposition, known as pseudogout, in the TMJ. The patient had a smooth recovery with no facial weakness and reported an increase in maximal inter-incisal opening from 19 mm to 36 mm during the one-year follow-up examination after surgery. Leftward deviation of the mandible only occurred at maximum opening, and there were no changes in occlusion reported. Pain and swelling had completely resolved.

Fig. 1.Radiographic evaluation pre and post-surgical excision. (A) illustrates the coronal view of a computed tomography (CT) scan prior to surgical intervention, while (B) represents the axial view of the CT scan before surgery. Conversely, (C) depicts the radiological findings following the surgical excision of the lesion in a coronal view, and (D) presents the axial view of the CT scan.

Fig. 2.Surgical excision. (A) shows the clinical appearance following surgical removal of superficial tissue over the temporomandibular joint (TMJ), displaying nodular, friable, gritty granulomatous tissue. (B) represents the surgical specimens, and (C) shows the TMJ with the mass completely removed.
To find relevant studies about calcium pyrophosphate dihydrate crystal deposition disease in the temporomandibular joint, a search was conducted in the following electronic databases PubMed, Web of Science and Scopus following the PRISMA guidelines [15]. For the PRISMA checklist, please see Supplementary material. The search terms used were “Calcium pyrophosphate dihydrate crystal deposition disease temporomandibular joint”, “CPPD temporomandibular joint” and “Pseudogout temporomandibular joint”. Keywords and Medical Subject Headings (MeSH) terms were used to combine the search on the aforementioned databases. In addition, the “Related articles” option on the PubMed homepage was considered, and a manual search of article references was conducted to capture any additional relevant reports. The search spanned from 01 January 1980, to 31 January 2024. The review has been registered in PROSPERO with the Identification Number (ID) number CRD42024558402. The full list of keywords used are:
- (“chondrocalcinosis” [MeSH Terms] OR “chondrocalcinosis” [All Fields] OR “pseudogout” [All Fields]) AND (“temporomandibular joint” [MeSH Terms] OR (“temporomandibular” [All Fields] AND “joint” [All Fields]) OR “temporomandibular joint” [All Fields])
- (“chondrocalcinosis” [MeSH Terms] OR “chondrocalcinosis” [All Fields] OR (“calcium” [All Fields] AND “pyrophosphate” [All Fields] AND “dihydrate” [All Fields] AND “crystal” [All Fields] AND “deposition” [All Fields] AND “disease” [All Fields]) OR “calcium pyrophosphate dihydrate crystal deposition disease” [All Fields]) AND (“temporomandibular joint” [MeSH Terms] OR (“temporomandibular” [All Fields] AND “joint” [All Fields]) OR “temporomandibular joint” [All Fields])
For the review, only the studies that met the following criteria were included: (i) they were original case series or case reports, (ii) they documented Pseudogout, and (iii) they involved the temporomandibular joint in patients of any age. Articles that are not specific to the topic or are published in languages other than English were excluded; in particular, it was necessary to prevent misinterpretation by authors whose second language is English. Reports involving tumor calcinosis or with insufficient data.
Two of the authors (MV; AC) thoroughly reviewed literature data and carefully selected all the studies that met the eligibility criteria. All relevant data, such as demographics, clinical characteristics, outcomes and follow-up, were extracted and recorded from each study. Any discrepancies were resolved through discussion with the senior authors (DM, LGN).
The initial plan was to conduct a meta-analysis for this systematic review. However, since the studies showed a relevant degree of heterogeneity, it was not feasible to proceed with this approach. As a result, a descriptive analysis of the studies was conducted instead.
The main results analyzed in the studies were:
Provide an estimate of the real prevalence of CPPD;
Investigate the co-occurrence of medical conditions and underlying systemic factors that contribute to the development of CPPD;
Describe the most common signs and symptoms related to CPPD;
Identify the most effective treatment option.
Secondary Outcomes were:
Evaluate the presence of relapse;
Highlight the best radiological methods to study this pathology.
Two authors (MV/MR) evaluated these aspects for each study: incomplete data evaluation, evaluation report, and other sources of biased selective results. Each research study underwent classification as either low risk, high risk or undefined risk. Any discrepancies in the assessment process were resolved through deliberation or mediation involving a third researcher (DM).
Regrettably, the presence of solely case reports and case series, along with significant disparities in treatments administered even within the same patient series, precluded a comprehensive assessment of bias.
A total of 125 papers were found. After the screening procedures for inclusion in the review, 64 case report/case series were identified. The flowchart depicting the article selection process for all search queries is available in Fig. 3.

Fig. 3.Flowchart illustrating the procedure for article selection. Legend: CPPD: Calcium pyrophosphate dihydrate deposition disease; TMJ: temporomandibular joint.
Table 1 (Ref. [8, 9, 10, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]) presents the characteristics of the studies included, which were published between 1982 and 2023. These studies encompassed a total of 64 papers, involving 74 patients. Females outnumbered males (F:M = 46:28). The mean age at the moment of diagnosis ranged between 60.95 ± 13.02. Almost all patients (70 out of 74) had a unilateral TMJ involvement. Only 22 had a recorded medical history concerning any possible comorbidities. The three most frequent comorbidities were hypertension, hypercholesterolemia and diabetes. Additionally, there were four cases of patients suffering from gout.
| Study first Author | Year | N of patients | Sex | Age | Localization | History of the lesion | Systemic diseases |
| Good et al. [20] | 1982 | 1 | M | 59 | Right TMJ | Acute origin | Not reported |
| Zemplenyi et al. [29] | 1985 | 2 | F | 51 | Left TMJ | No description | Not reported |
| Gross et al. [30] | 1987 | 3 | F | 59 | Left TMJ | History of generalized arthritis affecting multiple joints, which has been managed with localized steroid injections. | Not reported |
| Hutton et al. [22] | 1987 | 4 | F | 78 | Right TMJ | Acute origin | Not reported |
| 5 | F | 76 | Right TMJ | Acute origin | Not reported | ||
| 6 | F | 68 | Right TMJ | Acute origin | Polymyalgia rheumatica, for which she had been treated with prednisolone | ||
| Kamatani et al. [43] | 1987 | 7 | M | 57 | Left TMJ | Trauma 6 year before with mild symptoms | Diabetes mellitus |
| Mogi et al. [61] | 1987 | 8 | F | 54 | Right TMJ | 8 years history of pain and swelling since thel esion was highlighted | Not reported |
| Lambert et al. [32] | 1990 | 9 | M | 41 | Left TMJ | 18 years since the lesion was highlighted | Not reported |
| Dijkgraaf et al. [44] | 1992 | 10 | F | 53 | Left TMJ | 8 months before had a loud click in her TMJ with pain and disk displacement at the MRI | Not reported |
| Magno et al. [33] | 1992 | 11 | F | 53 | Left TMJ | The patient was involved in a motor vehicle accident many years ago, during which she suffered a cervical vertebral fracture | Not reported |
| Chuong et al. [46] | 1995 | 12 | F | 65 | Bilateral TMJ | The patient has an 8-year history of bilateral temporomandibular joint (TMJ) pain, periodic popping and locking, and frequent restricted mouth opening, particularly during episodes of frank preauricular swelling | Hypothyroidism, hypertension, hiatal hernia, and von Willebrand’s disease. |
| Pynn et al. [45] | 1995 | 13 | M | 58 | Left TMJ | The patient presented with a history of swelling persisting for 18 months. The swelling manifested abruptly and maintained its size until one month prior to the referral, when it significantly increased before gradually returning to its original size following a two-week course of oral acetylsalicylic acid | Not reported |
| Allias-Montmayeur et al. [23] | 1997 | 14 | M | 52 | Left TMJ | Patient presents with a limited mouth opening, mandibular deviation, and pre-auricular swelling persisting for 4 years | Not reported |
| 15 | F | 46 | Left TMJ | Acute attack of pain in the left TMJ. Same episode 3 years before. Pre-auricular swelling | Not reported | ||
| Kurihara et al. [51] | 1997 | 16 | M | 85 | Right TMJ | Swelling in the right TMJ region, which he had suffered for 2 years. Pain during mastication | Not reported |
| Onodera et al. [69] | 1997 | 17 | F | 48 | Left TMJ | Swelling for 3 years, restricted mouth opening | Not reported |
| Vargas et al. [70] | 1997 | 18 | F | 66 | Left TMJ | 2-month history of swelling with tenderness over the left pre-auricular region with pain with restriction of jaw opening | Not reported |
| Jordan et al. [16] | 1998 | 19 | M | 80 | Right TMJ | The patient presented with a one-month history of sudden worsening of right-sided hearing loss following descent in an airplane flight. He denied experiencing any temporomandibular joint (TMJ) pain, trismus, jaw popping, or clicking. A right-sided middle ear effusion was observed and treated with myringotomy, but reaccumulated rapidly. | Hypertension, hypercholesterolemia, and gout |
| Strobl et al. [71] | 1998 | 20 | F | 51 | Left TMJ | The patient presented with an 18-month history of progressive left-sided temporomandibular joint (TMJ) pain and trismus. There was no reported history of trauma or systemic joint disease | Not reported |
| Goudot et al. [72] | 1999 | 21 | F | 63 | Left TMJ | 10-year history of left TMJ pain and restricted mouth opening | Not reported |
| Grant et al. [28] | 1999 | 22 | F | 65 | Left TMJ | The patient presented with a 2- to 3-month history of progressive left-sided facial fullness, discomfort, and intermittent facial swelling. The discomfort was alleviated after a course of antibiotic medications and prednisone for suspected parotiditis, although the swelling persisted. The patient denied experiencing any paresthesias, nasal issues, otalgia, or swallowing difficulties. Her medical history revealed longstanding bilateral middle ear infections, necessitating the placement of a left-sided myringotomy tube | Not reported |
| Nakagawa et al. [73] | 1999 | 23 | F | 60 | Right TMJ | The patient has a 1-year history of swelling in the right preauricular region and has reported a l-month history of TMJ discomfort and trismus | Not reported |
| 24 | F | 45 | Left TMJ | The patient reported a progressive increase in left temporomandibular joint (TMJ) pain, which commenced several years prior to seeking medical attention. The pain was described as a burning sensation and was exacerbated during jaw movement. | Not reported | ||
| Pynn et al. [50] | 1995 | 25 | M | 58 | Left TMJ | The patient presented with painless swelling in the left preauricular region persisting for approximately 18 months. The swelling had a sudden onset and remained unchanged in size until one month prior to referral, when it abruptly increased before slowly returning to its original size following two weeks of oral acetylsalicylic acid (aspirin) therapy | Not reported |
| Aoyama et al. [74] | 2000 | 26 | F | 45 | Left TMJ | The patient presented with painful swelling in the left preauricular area and reported experiencing a clicking noise when opening her mouth for over 30 years. Additionally, eight years ago, she experienced pain in the same area, which subsided following occlusal adjustment and the prescription of a muscle relaxant | Not reported |
| Li-Yu et al. [34] | 2000 | 27 | F | 72 | Left TMJ | Excruciating pain in her left ear. Initial treatment for suspected otitis media included antibiotics with no improvement noted. The pain gradually extended to her left cheek and jaw, with some localized swelling and tenderness over the TMJ area | Hysterectomy in 1985 and breast cancer in 1993 |
| Eriksson et al. [75] | 2001 | 28 | F | 72 | Right TMJ | The patient has been experiencing chronic pain in the right TMJ for several years, with the pain intensifying over time and becoming more pronounced during chewing. Additionally, the patient has observed a minor swelling in the joint and has reported experiencing clicking sensations. The patient also recalls experiencing trauma to the chin during childhood | Not reported |
| Olin et al. [24] | 2001 | 29 | F | 51 | Left TMJ | The patient developed a pre-auricular swelling on the left side that has been persistent for two months | Not reported |
| Osano et al. [76] | 2003 | 30 | M | 40 | Left TMJ | The patient presented with pain and swelling in his left TMJ. He had previously encountered similar symptoms two years ago, which were alleviated with intravenous antibiotic infusion | Not reported |
| Marsot-Dupuch et al. [35] | 2004 | 31 | F | 70 | Right TMJ | The patient has a 10-year history of right TMJ pain and an ear lump. She was referred due to acute exacerbation, new onset of left TMJ pain, and right-sided hearing loss | Not reported |
| 32 | M | 53 | Left TMJ | The patient presents with a 1-year history of acute left aural fullness and conductive hearing loss. Examination revealed otitis media, for which the patient had previously undergone myringotomy and tube placement at an external medical facility, with no improvement in symptoms. The patient denied experiencing otorrhea, otalgia, vertigo or tinnitus | Diabetes mellitus | ||
| Meul et al. [77] | 2005 | 33 | M | 54 | Left TMJ | Patient has a 3-year history of painless swelling in the left preauricular region | The individual experienced paraplegia as a result of a motor-vehicle accident 25 years ago, and also has non-insulin dependent diabetes |
| Smolka et al. [25] | 2005 | 34 | F | 74 | Left TMJ | Extremely painful preauricular swelling on the left side | Not reported |
| Nicholas et al. [52] | 2007 | 35 | F | 35 | Left TMJ | The patient presented with a 2-month history of left-sided otalgia and an external auditory canal lesion that did not respond to antibiotic treatment. Additionally, the patient had previously experienced temporomandibular joint (TMJ) pain four years ago and had received an appliance at that time, which proved ineffective | Not reported |
| Mikami et al. [78] | 2008 | 36 | M | 59 | Left TMJ | In April 2006, the patient experienced intense pain in the left TMJ region. Despite undergoing physical therapy treatment at a previous medical facility, there was no improvement in the symptoms | Not reported |
| Naqvi et al. [36] | 2008 | 37 | M | 35 | Left TMJ | The patient has been experiencing discomfort and pain in the TMJ area for the past four years. Additionally, he has been suffering from acute severe pain in his left ear, with a potential pustule within the external auditory canal, in conjunction with TMJ discomfort. Although he received treatment for an ear infection, the lesion in the external auditory canal did not resolve | Not reported |
| Reynolds et al. [79] | 2008 | 38 | F | 52 | Left TMJ | The patient presented with longstanding and progressively worsening left TMJ pain. The pain occurred episodically, approximately twice per year, and persisted for 2 weeks during each episode. There were no identifiable precipitating factors. Additionally, the patient experienced regular discomfort when chewing for extended periods on the affected side | Not reported |
| Covani et al. [9] | 2009 | 39 | F | 74 | Right TMJ | Limited mouth opening and severe swelling on the right side of the face. The patient had a three-year history of limited mouth opening and painless swelling | Not reported |
| Kathju et al. [80] | 2010 | 40 | F | 78 | Left TMJ | The patient has reported experiencing intermittent pain in the left TMJ over the course of several years. Additionally, they have noted a gradual increase in swelling on the left cheek over the past year | Hypertension, peripheral vascular disease, history of deep venous thrombosis in both lower extremities, history of bladder cancer, melanoma, transient ischemic attack (TIA), and osteoporosis |
| Meng et al. [47] | 2011 | 41 | F | 64 | Left TMJ | 5-year history of chronic pain and swelling | Hypertension, hypercholesterolaemia and a gallbladder stone. |
| Sklenicka et al. [26] | 2011 | 42 | F | 58 | Right TMJ | The patient presents with a 2-month history of progressive swelling of the right TMJ accompanied by trismus and facial pain | Depression, for which she was on paroxetine. Previous surgical history was significant for bunionectomy, lower back surgery, and stapedectomy |
| Matsumura et al. [81] | 2012 | 43 | M | 46 | Right TMJ | Right temporomandibular pain | Mild depression |
| Nelson et al. [31] | 2012 | 44 | F | 89 | Right TMJ | No description | Liposarcoma of the right arm that had been treated with surgical resection 2 years earlier |
| Srinivasan et al. [27] | 2012 | 45 | F | 51 | Right TMJ | The patient presented with a two-month history of left ear pain originating from the TMJ, accompanied by swelling, discomfort while chewing, and mild hearing loss | Not reported |
| Zweifel et al. [48] | 2012 | 46 | M | 75 | Right TMJ | The patient experienced a single episode of TMJ open locking in his right jaw while chewing the previous day. The mandible repositioned spontaneously, but the patient subsequently noticed a slight opening in his bite on the same side. Additionally, he reported localized TMJ pain and swelling | Arterial hypertension, prostate hyperplasia, and malaria in 1994 |
| Lv et al. [17] | 2013 | 47 | M | 62 | Right TMJ | Approximately five years ago, the patient experienced unexplained swelling in the anterior region of their right external auditory canal. This swelling was not accompanied by localized pain or limitations in mouth opening. Subsequently, over the past two months, the individual noticed a decline in hearing in their right ear, which was not accompanied by symptoms such as tinnitus, ear pain, or discharge from the ear | History of high blood pressure, high cholesterol, high uric acid, chronic ex- tremity pain, gout or arthritis |
| Abdelsayed et al. [37] | 2014 | 48 | M | 60 | Left TMJ | Limited mouth opening for several years | Not reported |
| 49 | M | 75 | Right TMJ | The patient has a history of chronic pain in the right jaw accompanied by trismus persisting for 4 years. Over a period of 1 year, the patient experienced pain in the right ear, along with sensations of blockage and thumping tinnitus. Additionally, the patient reported hearing loss and intermittent episodes of positional off-balance sensation. The patient underwent right ear surgery for cholesteatoma | Not reported | ||
| 50 | F | 74 | Left TMJ | The patient had been suffering from painful swelling in the left TMJ for five years before seeking medical attention. The pain had intensified significantly in the month leading up to the examination, and the patient had also been experiencing hearing loss in her left ear | Not reported | ||
| Laviv et al. [54] | 2015 | 51 | F | 60 | Right TMJ | TMJ pain and limited mouth opening for 7 months despite various treatments, affecting daily activities | Generalized degenerative joint disease with symptoms in her back, shoulders, and toes. There was a strong family history of arthritis. No specific diagnosis had been made and routine rheumatoid screens were negative. Her medical history was important for allergy to penicillin, asthma, and thyroid disease. She took levothyroxine, omeprazole, and asthma medications as needed |
| Kudoh et al. [18] | 2017 | 52 | M | 38 | Right TMJ | The patient reported experiencing mild pain in the right chin and tip of the tongue. The onset of mild pain in the right chin occurred 2 months prior to admission, following which the patient received root canal treatment for the right lower second molar | Hyperlipidemia, gout, diabetes, and hyper- tension. These conditions were all well controlled with medication |
| Fuentes-Martinez et al. [62] | 2018 | 53 | F | 89 | Left TMJ | The patient has been experiencing TMJ pain for the past 5 years. She has a history of trauma in that area dating back 40 years; however, the trauma did not necessitate medical attention | Not reported |
| Kwon et al. [82] | 2018 | 54 | M | 72 | Left TMJ | The patient presented with pain and hardening of the area in front of the left ear. He had no significant prior medical conditions and experienced discomfort and crackling sensation when opening his mouth, a condition that had persisted for a couple of years | Not reported |
| Vellone et al. [83] | 2018 | 55 | F | 64 | Right TMJ | Right temporomandibular pain and limitation in mandibular movements | Not reported |
| De Jong et al. [38] | 2019 | 56 | M | 73 | Left TMJ | Twitching of the mouth and the sensation of fullness in the left ear, long-standing dizziness and imbalance | Not reported |
| Fan et al. [39] | 2019 | 57 | F | 87 | Right TMJ | The patient presented with complaints of bilateral ear fullness and a sensation of clogged ears accompanied by a slight decrease in hearing over the past 2 months. Additionally, she reported experiencing chronic facial pain that began 2 years ago, which has progressively worsened over the last 4 months. The pain was exacerbated during jaw movement. Furthermore, she noted the presence of pain on the right side of her throat, anosmia, and a loss of ability to taste food over the past 2 months | Chronic kidney disease, congestive heart failure, hypertension, lung nodules, and COPD |
| Sha et al. [84] | 2019 | 58 | F | 57 | Right TMJ | Right TMJ pain for more than 5 years. | Not reported |
| Abou-Foul et al. [53] | 2020 | 59 | M | 56 | Left TMJ | Progressive left sided TMJ discomfort, swelling and trismus | Not reported |
| Choi et al. [19] | 2020 | 60 | F | 61 | Bilateral TMJ | The patient presented with initial complaints of bilateral TMJ pain and a history of decreased mouth opening spanning several years | Not reported |
| 61 | F | 66 | Bilateral TMJ | The patient initially reported experiencing limited mouth opening and persistent joint pain subsequent to a motor vehicle accident that occurred 8 months ago | Hypothyroidism | ||
| 62 | M | 72 | Right TMJ | The patient presented with acute pain in the right TMJ, swelling in front of the ear, and restricted mouth opening. He had a 20-year history of right TMJ disease, which was managed through non-invasive methods | Gout, type II diabetes, and essential tremors | ||
| Gomez Serrano et al. [40] | 2020 | 63 | M | 73 | Left TMJ | Left-sided hearing loss | Not reported |
| Hotokezaka et al. [10] | 2020 | 64 | F | 59 | Left TMJ | The patient, with a 4-year history of left cheek swelling, pain and trismus, was referred due to acute exacerbation of left cheek pain and trismus | Not reported |
| Houghton et al. [85] | 2020 | 65 | F | 55 | Right TMJ | The patient presents with a painless right-sided pre-auricular mass that has been progressively increasing in size over the past 2 years | Not reported |
| Loro et al. [86] | 2020 | 66 | F | 40 | Bilateral TMJ | The patient presented with swelling in the left preauricular region. She had a significant history of TMJ pain and restricted jaw movements. Fourteen years prior, she underwent bilateral discectomy and synovectomy. Subsequently, three years ago, she underwent arthroplasty and synovectomy in the right TMJ due to severe pain and substantial reduction in TMJ function | Asthma, hypertension, and psoriatic arthritis with involvement of both TMJs diagnosed over 20 years ago |
| Tang et al. [41] | 2021 | 67 | F | 46 | Right TMJ | The patient has been experiencing persistent pain and discomfort in the right temporal region for a duration exceeding three months | Diabetes mellitus |
| 68 | M | 52 | Left TMJ | The patient has been experiencing a mass in the left TMJ for the past 6 years | Not reported | ||
| Bschorer et al. [8] | 2022 | 69 | F | 53 | Left TMJ | The patient presented with progressive pain in the left TMJ and noted a progressive asymmetry of the face attributed to swelling in the left preauricular region. She reported that these symptoms had slowly developed over the past decade | Not reported |
| Dang et al. [49] | 2022 | 70 | M | 65 | Left TMJ | The patient has been experiencing a progressively worsening left posterior open bite and mild, dull, constant left pre-auricular tenderness for the past 4–5 months | Hypertension and ulcerative colitis |
| Murahashi et al. [87] | 2022 | 71 | M | 61 | Right TMJ | The patient has been experiencing persistent preauricular pain in the right cheek and restricted mouth opening for more than 6 months | Hypertension and type 2 diabetes mellitus |
| Takeda et al. [63] | 2022 | 72 | F | 83 | Right TMJ | First noticed the pain 3 years earlier | Not reported |
| Terauchi et al. [55] | 2022 | 73 | M | 47 | Right TMJ | Persistent pain in the right TMJ and trismus | Not reported |
| Bukawa et al. [21] | 2023 | 74 | F | 73 | Left TMJ | Acute swelling at the closure site of the left ear | Hypertension, osteoporosis, and hyperlipidemia, and she has been receiving anti-RANKL preparations for 2 years, she also took an angiotensin II receptor blocker, pravastatin sodium |
| Legend: M: Male; F: Female; MRI: Magnetic Resonance; COPD: Chronic obstructive pulmonary disease; RANKL: receptor activator of nuclear factor kappa beta ligand. |
Out of the 74 cases, there were only 12 patients [16, 21, 22, 23, 24, 25, 26, 27, 28] reporting sudden symptom, such as pain or dysfunction for less than 3 months. Three of those cases [29, 30, 31] did not have a description of the clinical history of the chief complaint, while the remaining 59 patients have been experiencing chronic signs and symptoms for several years. At the time of diagnosis, 83.7% of patients (62 out of 74) reported experiencing pain. Additionally, 71.6% (53 out of 74) exhibited both objective (a decrease in interincisal distance to less than 35 mm) and subjective mouth-opening limitation. Swelling was the third most common clinical sign, observed in 40.54% of patients, with 30 out of 74 individuals experiencing this symptom. Furthermore, 14 patients [16, 17, 28, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42] were referred for hearing loss, which was confirmed in all cases by instrumental analysis. Finally, a total of 11 patients [23, 35, 43, 44, 45, 46, 47, 48, 49, 50], which accounts for 14.86% of the group, reported experiencing changes in their dental occlusion. All the signs and symptoms summarized could be found in Table 2 (Ref. [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]).
| Study first Authors | Year | N of patients | Occlusal changes | Pain | Jaw disfunction | Hearing loss |
| Good et al. [20] | 1982 | 1 | 0 | 1 | 1 | 0 |
| Zemplenyi et al. [29] | 1985 | 2 | 0 | 1 | 1 | 0 |
| Gross et al. [30] | 1987 | 3 | 0 | 1 | 1 | 0 |
| Hutton et al. [22] | 1987 | 4 | 0 | 1 | 1 | 0 |
| 5 | 0 | 1 | 1 | 0 | ||
| 6 | 0 | 1 | 1 | 0 | ||
| Kamatani et al. [43] | 1987 | 7 | 1 | 0 | 1 | 0 |
| Mogi et al. [61] | 1987 | 8 | 0 | 1 | 1 | 0 |
| Lambert et al. [32] | 1990 | 9 | 0 | 0 | 1 | 1 |
| Dijkgraaf et al. [44] | 1992 | 10 | 1 | 1 | 1 | 0 |
| Magno et al. [33] | 1992 | 11 | 0 | 1 | 0 | 1 |
| Chuong et al. [46] | 1995 | 12 | 1 | 1 | 1 | 0 |
| Pynn et al. [45] | 1995 | 13 | 1 | 0 | 0 | 0 |
| Allias-Montmayeur et al. [23] | 1997 | 14 | 1 | 1 | 1 | 0 |
| 15 | 1 | 1 | 1 | 0 | ||
| Kurihara et al. [51] | 1997 | 16 | 0 | 1 | 0 | 0 |
| Onodera et al. [69] | 1997 | 17 | 0 | 0 | 1 | 0 |
| Vargas et al. [70] | 1997 | 18 | 0 | 1 | 1 | 0 |
| Jordan et al. [16] | 1998 | 19 | 0 | 0 | 0 | 1 |
| Strobl et al. [71] | 1998 | 20 | 0 | 1 | 1 | 0 |
| Goudot et al. [72] | 1999 | 21 | 0 | 1 | 1 | 0 |
| Grant et al. [28] | 1999 | 22 | 0 | 1 | 1 | 1 |
| Nakagawa et al. [73] | 1999 | 23 | 0 | 1 | 1 | 0 |
| 24 | 0 | 1 | 0 | 0 | ||
| Pynn et al. [50] | 1998 | 25 | 1 | 0 | 0 | 0 |
| Aoyama et al. [74] | 2000 | 26 | 0 | 1 | 1 | 0 |
| Li-Yu et al. [34] | 2000 | 27 | 0 | 1 | 1 | 1 |
| Eriksson et al. [75] | 2001 | 28 | 0 | 1 | 1 | 0 |
| Olin et al. [24] | 2001 | 29 | 0 | 0 | 0 | 0 |
| Osano et al. [76] | 2003 | 30 | 0 | 1 | 1 | 0 |
| Marsot-Dupuch et al. [35] | 2004 | 31 | 1 | 1 | 1 | 1 |
| 32 | 0 | 1 | 1 | 1 | ||
| Meul et al. [77] | 2005 | 33 | 0 | 1 | 1 | 0 |
| Smolka et al. [25] | 2005 | 34 | 0 | 1 | 1 | 0 |
| Nicholas et al. [52] | 2007 | 35 | 0 | 1 | 0 | 0 |
| Mikami et al. [78] | 2008 | 36 | 0 | 1 | 0 | 0 |
| Naqvi et al. [36] | 2008 | 37 | 0 | 1 | 0 | 1 |
| Reynolds et al. [79] | 2008 | 38 | 0 | 1 | 1 | 0 |
| Covani et al. [9] | 2009 | 39 | 0 | 1 | 1 | 0 |
| Kathju et al. [80] | 2010 | 40 | 0 | 1 | 1 | 0 |
| Meng et al. [47] | 2011 | 41 | 1 | 1 | 1 | 0 |
| Sklenicka et al. [26] | 2011 | 42 | 0 | 1 | 1 | 0 |
| Matsumura et al. [81] | 2012 | 43 | 0 | 1 | 1 | 0 |
| Nelson et al. [31] | 2012 | 44 | 0 | 1 | 0 | 0 |
| Srinivasan et al. [27] | 2012 | 45 | 0 | 0 | 1 | 0 |
| Zweifel et al. [48] | 2012 | 46 | 1 | 1 | 0 | 0 |
| Lv et al. [17] | 2013 | 47 | 0 | 0 | 0 | 1 |
| Abdelsayed et al. [37] | 2014 | 48 | 0 | 1 | 1 | 0 |
| 49 | 0 | 1 | 1 | 1 | ||
| 50 | 0 | 1 | 0 | 0 | ||
| Laviv et al. [54] | 2015 | 51 | 0 | 1 | 1 | 0 |
| Kudoh et al. [18] | 2017 | 52 | 0 | 1 | 1 | 0 |
| Fuentes-Martinez et al. [62] | 2018 | 53 | 0 | 1 | 0 | 0 |
| Kwon et al. [82] | 2018 | 54 | 0 | 1 | 1 | 0 |
| Vellone et al. [83] | 2018 | 55 | 0 | 1 | 1 | 0 |
| De Jong et al. [38] | 2019 | 56 | 0 | 1 | 0 | 1 |
| Fan et al. [39] | 2019 | 57 | 0 | 1 | 1 | 1 |
| Sha et al. [84] | 2019 | 58 | 0 | 1 | 0 | 0 |
| Abou-Foul et al. [53] | 2020 | 59 | 0 | 1 | 1 | 0 |
| Choi et al. [19] | 2020 | 60 | 0 | 1 | 1 | 0 |
| 61 | 0 | 1 | 1 | 0 | ||
| 62 | 0 | 1 | 1 | 0 | ||
| Gomez Serrano et al. [40] | 2020 | 63 | 0 | 0 | 0 | 1 |
| Hotokezaka et al. [10] | 2020 | 64 | 0 | 1 | 1 | 0 |
| Houghton et al. [85] | 2020 | 65 | 0 | 0 | 0 | 0 |
| Loro et al. [86] | 2020 | 66 | 0 | 1 | 1 | 0 |
| Tang et al. [41] | 2021 | 67 | 0 | 1 | 1 | 0 |
| 68 | 0 | 1 | 0 | 1 | ||
| Bschorer et al. [8] | 2022 | 69 | 0 | 1 | 0 | 0 |
| Dang et al. [49] | 2022 | 70 | 1 | 1 | 1 | 0 |
| Murahashi et al. [87] | 2022 | 71 | 0 | 1 | 1 | 0 |
| Takeda et al. [63] | 2022 | 72 | 0 | 1 | 1 | 0 |
| Terauchi et al. [55] | 2022 | 73 | 0 | 1 | 1 | 0 |
| Bukawa et al. [21] | 2023 | 74 | 0 | 0 | 1 | 0 |
| Legend: 0: not present; 1: present. |
Blood tests were conducted on 28 patients as listed in Table 3 (Ref. [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87]). The majority of patients had normal biochemistry results, except for a few exceptions:
- Kurihara et al. [51] observed a very slight elevation of hyperuricemia;
- Grant et al. [28] highlighted elevated levels of serum calcium; ionized calcium; parathyroid hormone; and a low phosphate level;
- Nicholas et al. [52] demonstrated an elevated intact parathyroid hormone level and hypocalcemia;
- Meng et al. [47] reported a slightly higher phosphate and cholesterol;
- Abou-Foul et al. [53] identified a slightly elevated parathyroid hormone.
| Study first Author | Year | N of patients | Blood exams |
| Good et al. [20] | 1982 | 1 | Normal biochemistry |
| Zemplenyi et al. [29] | 1985 | 2 | Normal biochemistry |
| Gross et al. [30] | 1987 | 3 | Not reported |
| Hutton et al. [22] | 1987 | 4 | Not reported |
| 5 | Not reported | ||
| 6 | Not reported | ||
| Kamatani et al. [43] | 1987 | 7 | Normal biochemistry |
| Mogi et al. [61] | 1987 | 8 | Normal biochemistry |
| Lambert et al. [32] | 1990 | 9 | Normal biochemistry |
| Dijkgraaf et al. [44] | 1992 | 10 | Not reported |
| Magno et al. [33] | 1992 | 11 | Not reported |
| Chuong et al. [46] | 1995 | 12 | Not reported |
| Pynn et al. [45] | 1995 | 13 | Not reported |
| Allias-Montmayeur et al. [23] | 1997 | 14 | Not reported |
| 15 | Not reported | ||
| Kurihara et al. [51] | 1997 | 16 | Slight hyperuricemia (8.1 mg/dL) |
| Onodera et al. [69] | 1997 | 17 | Not reported |
| Vargas et al. [70] | 1997 | 18 | Not reported |
| Jordan et al. [16] | 1998 | 19 | Not reported |
| Strobl et al. [71] | 1998 | 20 | Normal biochemistry |
| Goudot et al. [72] | 1999 | 21 | Normal biochemistry |
| Grant et al. [28] | 1999 | 22 | Normal biochemistry except for elevated levels of serum calcium (11.9 mg/dL; normal range 8.9–10.2 mg/dL); ionized calcium (1.38 mmol/L; normal range 1.16–1.27 mmol/L); parathyroid hormone (122 pg/mL; normal range 21–69 pg/mL); and a low phosphate level (2.8 mg/dL; normal range 3–4.5 mg/dL) |
| Nakagawa et al. [73] | 1999 | 23 | Normal biochemistry |
| 24 | Not reported | ||
| Pynn et al. [50] | 1998 | 25 | Not reported |
| Aoyama et al. [74] | 2000 | 26 | Not reported |
| Li-Yu et al. [34] | 2000 | 27 | Normal biochemistry except for an elevated erythrocyte sedimentation rate of 66 mm/hr |
| Eriksson et al. [75] | 2001 | 28 | Not reported |
| Olin et al. [24] | 2001 | 29 | Not reported |
| Osano et al. [76] | 2003 | 30 | Normal biochemistry |
| Marsot-Dupuch et al. [35] | 2004 | 31 | Not reported |
| 32 | Not reported | ||
| Meul et al. [77] | 2005 | 33 | Normal biochemistry |
| Smolka et al. [25] | 2005 | 34 | Normal biochemistry |
| Nicholas et al. [52] | 2007 | 35 | Elevated intact parathyroid hormone level and hypocalcemia with no other metabolic abnormalities. |
| Mikami et al. [78] | 2008 | 36 | Not reported |
| Naqvi et al. [36] | 2008 | 37 | Not reported |
| Reynolds et al. [79] | 2008 | 38 | Normal biochemistry except for slight elevation in erythrocyte sedimentation rate to 22 (upper limit of normal 21) |
| Covani et al. [9] | 2009 | 39 | Normal biochemistry |
| Kathju et al. [80] | 2010 | 40 | Not reported |
| Meng et al. [47] | 2011 | 41 | Normal biochemistry except for lightly higher phosphate, 1.49 mmol/L (normal 0.81–1.46) and cholesterol 5.89 mmol/L (normal 3.10– 5.70) |
| Sklenicka et al. [26] | 2011 | 42 | Not reported |
| Matsumura et al. [81] | 2012 | 43 | Normal biochemistry, except for a positive hepatitis virus Type B infection |
| Nelson et al. [31] | 2012 | 44 | Not reported |
| Srinivasan et al. [27] | 2012 | 45 | Not reported |
| Zweifel et al. [48] | 2012 | 46 | Normal biochemistry |
| Lv et al. [17] | 2013 | 47 | Normal biochemistry |
| Abdelsayed et al. [37] | 2014 | 48 | Not reported |
| 49 | Not reported | ||
| 50 | Not reported | ||
| Laviv et al. [54] | 2015 | 51 | Normal biochemistry |
| Kudoh et al. [18] | 2017 | 52 | Not reported |
| Fuentes-Martinez et al. [62] | 2018 | 53 | Not reported |
| Kwon et al. [82] | 2018 | 54 | Not reported |
| Vellone et al. [83] | 2018 | 55 | Normal biochemistry |
| De Jong et al. [38] | 2019 | 56 | Not reported |
| Fan et al. [39] | 2019 | 57 | Not reported |
| Sha et al. [84] | 2019 | 58 | Normal biochemistry |
| Abou-Foul et al. [53] | 2020 | 59 | Slightly elevated parathyroid hormone but otherwise normal biochemistry |
| Choi et al. [19] | 2020 | 60 | Not reported |
| 61 | Not reported | ||
| 62 | Not reported | ||
| Gomez Serrano et al. [40] | 2020 | 63 | Not reported |
| Hotokezaka et al. [10] | 2020 | 64 | Not reported |
| Houghton et al. [85] | 2020 | 65 | Normal biochemistry |
| Loro et al. [86] | 2020 | 66 | Normal biochemistry |
| Tang et al. [41] | 2021 | 67 | Not reported |
| 68 | Not reported | ||
| Bschorer et al. [8] | 2022 | 69 | Not reported |
| Dang et al. [49] | 2022 | 70 | Normal biochemistry |
| Murahashi et al. [87] | 2022 | 71 | Normal biochemistry |
| Takeda et al. [63] | 2022 | 72 | Normal biochemistry |
| Terauchi et al. [55] | 2022 | 73 | Normal biochemistry |
| Bukawa et al. [21] | 2023 | 74 | Not reported |
In Table 4, the radiological examinations performed for the 74 patients were reported to achieve a diagnosis. 63 out of 74 (85.13%) had been studied with CT. Out of the total number of patients, 41 exhibited condylar degeneration. However, in 33 cases, there were no radiological signs of invasion of nearby tissues. Twenty-two patients experienced temporal bone resorption, with an invasion of the skull base by CPPD and affection of the meninges in 2 cases. 8 patients experienced a local invasion in the ear canal. Finally, in 2 cases, the Magnetic Resonance (MRI) revealed an involvement of the parotid gland by the neoformation.
In 9 cases [18, 21, 22, 23, 30, 44, 52] CPPD lesions were also identified in various joints, with knee and wrist being the most commonly involved.
| Radiological Examination | N of Patients |
| Only CT | 30 |
| Only MRI | 4 |
| Both CT and MRI | 29 |
| Ultrasound | 0 |
| RX (orthopantomography) | 7 |
| Both CT and RX | 4 |
| Legend: CT: computerized tomography; MRI: Magnetic Resonance; RX: Radiography. |
Out of the total 74 cases of CPPD, only three Authors [18, 22, 55] were able to identify it through radiological examination. In 21 cases, joint aspiration was performed to complete the diagnostic process. In 50 patients, the diagnostic process itself served as the treatment solution with complete removal of the lesion.
Table 5 reports the various methods used by different Authors to treat CPPD. The surgical approach is the most common, with varying degrees of invasiveness. The three papers that managed patients solely with drugs utilized different solutions.
| Type of Treatment | N of Patients |
| Only Follow-up | 12 |
| Medications | 3 |
| Surgical removal of the lesion | 26 |
| Arthroplasty and removal of the lesion | 13 |
| Condylectomy, removal of the lesion and joint reconstruction | 16 |
| Massive demolition (condyle, glenoid fossa, zygomatic arch, muscles…) and joint reconstruction | 4 |
- In the study by Good et al. [20] Indomethacin, administered at a dosage of 25 mg four times daily, was found to provide relief from pain within a few hours.
- Choi et al. [19] treated one of the three patients with colchicine without benefit, but reported an improvement with non-steroidal anti-inflammatory drugs (NSAIDs) during acute exacerbations. The second case in their case series was treated with a steroid injection in the TMJ. In both cases the pharmacological treatment was not detailed.
Only one relapse of CPPD was reported, in the paper of Dijkgraaf et al. [44], whose patient underwent arthroplasty and surgical removal of the lesion. However, after one year, he received further treatment which involved the insertion of temporalis fascia. This resulted in the resolution of symptoms and an improvement in function. Patients who only received follow-up or pharmacological treatment did not experience any changes in the lesion or symptoms during the follow-up period.
The follow-up period averaged 13.45 ± 23 months.
A systematic assessment of the literature on CPPD of the TMJ over the past decades allowed the identification of 61 new cases since the last comprehensive review by Pynn et al. [45], thus reaching a total of 75 cases, included the case reported in this manuscript. It is common for studies to focus on individual cases, with only a small number of publications describing multiple cases (only 6 out of 74). The current review assessed systematically all available publications from 1980 to date, providing a standpoint for describing the disease’s epidemiological characteristics.
Pseudogout, also known as Calcium pyrophosphate dihydrate deposition disease (CPPD), is a metabolic condition characterized by the accumulation of calcium pyrophosphate dihydrate crystals in the synovial fluid. This accumulation leads to the calcification of articular cartilage and can cause acute arthritis in a small subset of patients [56]. Various etiologies were proposed [57]: Hereditary, Sporadic (idiopathic), Associated with metabolic disease (Hyperparathyroidism, reaching, Hypophosphatasia, Rheumatoid arthritis, Hemochromatosis, Hypomagnesemia and Renal failure), Associated with trauma or surgery.
CPPD often develops in joints containing fibrocartilage such as the knee, wrist, hip, shoulder and elbow. While involvement in the TMJ is rare, it is common to find lesions larger than 1 cm. In some cases, the crystals cause complete destruction of the joint space and invade surrounding structures: masticator space, parotid space and skull base [58].
CPPD is usually of interest to middle-aged or older patients [45], as confirmed by their average age at the time of diagnosis reported in this review, which is around 60 years. Additionally, females are affected 1.6 times more frequently by this condition than males, and this trend has remained consistent across recent and past studies. The vast majority of cases (around 95%) showed a unilateral TMJ involvement as reported by Tamimi et al. [58].
The most common symptoms of this condition include pain (83.7% of patients), reduced mouth opening (71.6%), and swelling (40.5% of patients). Additionally, there are less common symptoms such as hearing loss (18.9%) and changes in dental occlusion (14.8%). These are common clinical manifestations of various temporomandibular joint disorders, such as chondromatosis of the TMJ [59], so that differential diagnosis may be a concern that explains a potential late diagnosis [60].
There are no frequently altered blood tests; the few papers [28, 47, 51, 52, 53] that had studied the patient by a hematological point of view reported only minimal variations that are not relevant for diagnostic purposes.
Imaging techniques such as MRI and CT can be useful in identifying joint changes. These techniques can also reveal the presence of cloud-like synovial calcification in cases of early/mild CPPD. In late/severe stages, a chunky, diffusely calcified mass with a ground-glass appearance may be detected [58]. MRI can be used to accurately detect the presence of calcification in early CPPD, while in severe stages with invasion of muscles [43, 61], parotid gland [29] and even brain structure [16], aiding in identifying soft tissue involvement and planning surgical treatment.
Williams et al. [57] had reported that TMJ is more commonly involved than previously reported in patients affected by peripheral calcific disease, with a higher ratio females:males. This was confirmed by 9 Authors [18, 20, 22, 23, 30, 44, 54] who showed the presence of a synchronous involvement of different major joints, in particular the knee and the wrist.
The presence of multiple crystals of calcium pyrophosphate dihydrate in the joint space can disrupt its function and may require surgical removal. This review found that out of 74 cases, 59 were treated surgically using various methods such as removal of the lesion, arthroplasty with lesion removal, condylectomy with joint replacement, and complete demolition with joint replacement. It is difficult to determine the superiority of any method over another due to the heterogeneity of the study samples in terms of type, duration, and size of the lesion. Additionally, early stage lesions may just be monitored during follow-up or treated with medication based on symptoms or joint lavage, which showed a very good effectiveness for several TMJ internal derangements [18, 19, 20, 21, 22, 35, 37, 39, 62, 63, 64, 65].
The included source studies exhibited heterogeneity in terms of diagnosis, treatment and follow-up, making it more suitable to conduct separate meta-analyses for the diagnosis/prevalence of CPPD in the TMJ and the different outcomes of treatment. However, the limited number of studies in this systematic review precludes their division into subgroups. The search was conducted in English, potentially resulting in the omission of records unindexed with English keywords. Due to the scarcity of source material, studies with uncertain and high risk of bias were included in the synthesis.
The strengths of this systematic review encompass the meticulous definition of eligibility criteria, the comprehensive nature of the search, and strict adherence to PRISMA guidelines.
The case report outlined in this paper has many similarities to the other cases described in the literature. Late diagnosis was a common theme, as suggested by previous research, and it must be remarked that dentists unfortunately play a negative role due to the focus on oral appliance treatment and/or occlusal approaches as a one-fits-all approach to all TMJ disorders [12, 66]. Such a concern was also pointed out in previous papers on late-stage surgical demanding lesions [67]. Imaging techniques were used to have an accurate depiction of the joint status and plan for surgery, in line with current standards [68]. Open surgery was chosen as the best option to remove the sizable lesion detected with CT. The postoperative recovery was smooth, indicating a positive prognosis and successful treatment outcome, consistent with other instances of CPPD of the TMJ.
As a general remark, data reported in this review could help researchers pinpoint areas for improvement in future studies. To enhance knowledge on CPPD of the TMJ, there must be better quality literature on the disease. Many case reports lacked information on the disease stages as well as detailed surgical technique descriptions. Future research should aim to furnish comprehensive details regarding the patient’s medical history, encompassing anamnesis and the duration of symptoms. This approach is essential for identifying potential risk factors associated with the onset and progression of the disease.
In conclusion, CPPD is a rare and locally invasive benign disease that seldom affects the TMJ. A case report of a patient exhibiting classic CPPD symptoms has been presented, along with a comprehensive review of related literature from the past few decades. The review included 74 cases of CPPD in the TMJ, with a ratio of 1.6 females to every male and an average age of around 60 years. Bilateral localization was observed only in four cases. Although all cases showed varying degrees of hard and soft tissue invasion, thus making it not possible to generalize findings, there is a lack of information regarding the relationship between a possible extra-articular extension and time. In any case, late diagnosis is a common concern due to the often-unspecific symptoms. While surgery has the preferred treatment option for most of the authors and is mandatory for late stage lesions, a conservative approach may be considered in the early stages. The recurrence rate is extremely low, with only one case reported in the literature.
This review has demonstrated its efficacy in establishing the correct pathway for the diagnosis and management of suspected TMJ CPPD cases.
Further research is needed to establish a disease staging system based on the involvement of both articular and extra-articular tissues. This will, in turn, facilitate the standardization of TMJ CPPD treatment according to the localized invasiveness of the lesion.
Data are available upon reasonable request.
MV, DM, AC and LGN—wrote and organized the article; MF, EFC and MR—revised and edited the article; LGN, DM—designed the retrospective analysis; LGN, MR and MV—treated and performed the follow-up of the patient. All authors participated in the analysis of the literature.
The protocol for studying temporomandibular disorders and their surgical treatment was approved in 2018 at the Maxillofacial Surgery Unit of Ca’Foncello Hospital in Treviso (Italy). Ethical Committee approval numbered 581/CE Marca. Informed consent to participate in the study was obtained from participant.
Thanks for the histopathological examination of the specimen to Francesca Baciorri from the Department of Pathology and Molecular Genetics at the University of Padova’s Ca’ Foncello Hospital in Treviso, Italy.
This research received no external funding.
The authors declare no conflict of interest.
Supplementary material associated with this article can be found, in the online version, at https://files.jofph.com/ files/article/1899699082825220096/attachment/ Supplementary%20material.docx.